ARGENX SE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 349.3 EUR | +0.90% |
|
+3.56% | +1.69% |
Chart calendar argenx SE
e0eb35b6f130ba2eafa857c1cd05c._JhNXsnQHxGNBJqTj_JitcFzAlEuTmq_pyDExkWac8s.mdEfJvykT1DSbN_S5L0p4IoCNydqF1j9l1CW_3XTNp7KyXgEqOVqe_Rl8Q~82ec289c6c855a5eb486de89edcb46a1
Upcoming events on argenx SE
Past events on argenx SE
| 17/04/2024 22:42 | American Academy of Neurology Meeting - Neelam Goyal |
| 17/04/2024 18:45 | American Academy of Neurology Meeting - Jana Podhorna |
| 17/04/2024 18:45 | American Academy of Neurology Meeting - Srikanth Muppidi |
| 17/04/2024 18:45 | American Academy of Neurology Meeting - Vera Bril |
| 17/04/2024 18:45 | American Academy of Neurology Meeting - Jana Podhorna |
| 16/04/2024 16:15 | American Academy of Neurology Meeting - Jeffrey Allen |
| 15/04/2024 18:45 | American Academy of Neurology Meeting - James Howard |
| 15/04/2024 18:45 | American Academy of Neurology Meeting - Tuan Vu |
| 12/03/2024 19:35 | Barclays Global Healthcare Conference |
| 11/03/2024 18:40 | Leerink Partners Global Biopharma Conference |
| 04/03/2024 16:10 | TD Cowen Health Care Conference |
| 29/02/2024 13:30 | Q4 2023 Earnings Call |
| 29/02/2024 06:00 | Q4 2023 Earnings Release |
| 08/01/2024 17:00 | JPMorgan Healthcare Conference |
| 20/12/2023 13:30 | ADDRESS Topline Study Results Call |
| 28/11/2023 13:30 | ADVANCE-SC Topline Study Results Call |
| 13/11/2023 | Jefferies London Healthcare Conference |
| 07/11/2023 | Truist Securities Healthcare Conference |
| 07/11/2023 15:30 | Guggenheim Securities Inflammation & Immunology Conference |
| 02/11/2023 | American Association of Neuromuscular & Electrodiagnostic Medicine Meeting - Poster No:152 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 82,6 80,2 2.96% | 54,5 59,0 -7.57% | 486 450 8.14% | 420 400 5.04% | 1 171 1 111 5.41% | 1 682 |
|
EBITDA Million EUR | Released Forecast Spread | -176 -139 -27.19% | -414 -407 -1.74% | -310 -320 3.13% | -580 -671 13.54% | 0,00 -325 - | -192 |
|
EBIT Million EUR | Released Forecast Spread | -179 -143 -24.77% | -418 -424 1.51% | -314 -332 5.44% | -679 -709 4.21% | -392 -345 -13.59% | -196 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -158 -105 -50.8% | -526 -471 -11.77% | -360 -355 -1.6% | -688 -797 13.67% | -281 -290 3.02% | -109 |
|
Net income Million EUR | Released Forecast Spread | -163 -106 -53.34% | -529 -484 -9.2% | -368 -368 0.1% | -669 -786 14.88% | -272 -245 -11.08% | -137 |
|
EPS EUR | Released Forecast Spread | -4,22 -2,64 -60.08% | -11,7 -10,7 -8.98% | -7,20 -6,76 -6.61% | -12,3 -14,1 12.95% | -4,76 -4,28 -11.31% | -2,48 |
| Announcement Date | 27/02/20 | 04/03/21 | 03/03/22 | 02/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 31,3 41,3 -24.34% | 40,4 16,4 146.37% | 29,8 14,5 105.62% | 84,1 42,3 98.63% | 146 118 23.22% | 172 167 2.58% | 310 302 2.69% | 208 180 15.15% | 254 229 11.05% | 461 448 3.08% | 320 286 12.17% | 386 336 14.74% | 699 675 3.62% | 374 | 400 | 436 | 477 | 504 | |
|
EBITDA Million EUR | Released Forecast Spread | -198 -204 2.85% | -212 -249 14.93% | -170 -264 35.5% | -208 -204 -2.09% | -114 | -104 | -95,5 | -69,0 | -70,6 | -72,6 | -79,6 | -53,1 | |||||||
|
EBIT Million EUR | Released Forecast Spread | -94,1 -46,2 -103.63% | -208 -226 8.04% | -211 -250 15.55% | -172 -244 29.44% | -207 -194 -6.78% | -108 -136 20.55% | -305 -312 2.28% | -93,8 -116 18.88% | -92,2 -89,9 -2.61% | -186 -160 -16.48% | -76,0 -89,9 15.5% | -128 -88,5 -44.54% | -202 -128 -57.93% | -56,6 | -56,6 | -41,7 | -29,7 | 19,4 | |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -113 -42,8 -165.01% | -221 -228 3.12% | -218 -248 12.03% | -214 -235 8.97% | -239 -193 -23.81% | -38,9 -158 75.37% | -266 -344 22.52% | -68,9 -110 37.55% | -75,7 -77,8 2.65% | -145 -154 6.04% | -78,5 -78,7 0.26% | -56,5 -74,5 24.24% | -133 -110 -21.02% | -37,2 | -35,2 | -17,9 | -6,04 | 33,1 | |
|
Net income Million EUR | Released Forecast Spread | -118 -42,8 -175.29% | -214 -219 2.01% | -425 -416 -2.28% | -215 -248 13.23% | -206 -235 12.27% | -233 -194 -20.18% | -36,4 -159 77.14% | -258 -335 22.97% | -26,1 -113 76.84% | -85,2 -76,7 -11.16% | -111 -154 27.65% | -68,5 -82,3 16.8% | -91,5 -71,0 -28.87% | -159 -110 -43.94% | -38,2 | -38,0 | -21,9 | -12,0 | 38,3 |
|
EPS EUR | Released Forecast Spread | -4,29 -3,76 -14.1% | -3,76 -4,59 18.08% | -4,23 -5,03 15.84% | -0,66 -3,14 78.97% | -0,47 -2,44 80.76% | -1,53 -1,62 5.73% | -1,18 -2,14 45.04% | -1,55 -2,16 28.16% | -0,60 | -1,50 | -1,69 | -1,09 | |||||||
| Announcement Date | 27/02/20 | 03/03/22 | 03/03/22 | 05/05/22 | 28/07/22 | 27/10/22 | 02/03/23 | 02/03/23 | 04/05/23 | 27/07/23 | 27/07/23 | 31/10/23 | 29/02/24 | 29/02/24 | - | - | - | - | - |
More events
Past sector events for argenx SE
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ARGX Stock
- Calendar argenx SE
